Viewing Study NCT06918132


Ignite Creation Date: 2025-12-24 @ 9:40 PM
Ignite Modification Date: 2025-12-29 @ 11:30 PM
Study NCT ID: NCT06918132
Status: RECRUITING
Last Update Posted: 2025-12-12
First Post: 2025-03-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer
Sponsor: Mayo Clinic
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module